(Q43674954)

25 November 2017

title

Effects of fenofibrate and gemfibrozil on plasma homocysteine (English)

1 reference

25 November 2017

0 references

S Westphal

1

1 reference

25 November 2017

J Dierkes

series ordinal

2

1 reference

25 November 2017

C Luley

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

358

1 reference

25 November 2017

issue

9275

1 reference

25 November 2017

page(s)

39-40

1 reference

Serum homocysteine increases after therapy with fenofibrate or bezafibrate

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905271-5

7 January 2021

Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905271-5

7 January 2021

Effect of gemfibrozil on serum levels of prostacyclin and precursor fatty acids in hyperlipidemic patients with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905271-5

7 January 2021

Implication of fibrate therapy for homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905271-5

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2905271-5

7 January 2021

10.1016/S0140-6736(00)05271-5

Identifiers

DOI

1 reference

25 November 2017

1 reference